SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013741
Filing Date
2020-11-12
Accepted
2020-11-12 17:17:05
Documents
55
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycc-20200930x10q.htm 10-Q 1004196
2 EX-10.1 cycc-20200930ex1017c6286.htm EX-10.1 165884
3 EX-10.2 cycc-20200930ex1028db6db.htm EX-10.2 146354
4 EX-31.1 cycc-20200930ex311f1ffd5.htm EX-31.1 14853
5 EX-31.2 cycc-20200930ex31268b5ad.htm EX-31.2 15425
6 EX-32.1 cycc-20200930ex32199af55.htm EX-32.1 5130
7 EX-32.2 cycc-20200930ex322f79b08.htm EX-32.2 5474
  Complete submission text file 0001558370-20-013741.txt   4320513

Data Files

Seq Description Document Type Size
8 EX-101.INS cycc-20200930.xml EX-101.INS 682399
9 EX-101.SCH cycc-20200930.xsd EX-101.SCH 32599
10 EX-101.CAL cycc-20200930_cal.xml EX-101.CAL 36116
11 EX-101.DEF cycc-20200930_def.xml EX-101.DEF 143757
12 EX-101.LAB cycc-20200930_lab.xml EX-101.LAB 293331
13 EX-101.PRE cycc-20200930_pre.xml EX-101.PRE 251796
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 201308013
SIC: 2834 Pharmaceutical Preparations